VKH
NERV icon

Virtu KCG Holdings’s Minerva Neurosciences NERV Stock Holding History

Virtu KCG Holdings’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$297K Buy
+4,192
New +$271K 0.01% 1682
2015
Q2 		– Sell
-2,235
Closed -$89K – 3613
2015
Q1 		$89K Buy
+2,235
New +$92.5K ﹤0.01% 2680

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Virtu KCG Holdings's NERV Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Minerva Neurosciences (NERV) in Q2 2017: 4,192 shares worth $297K. The stake represents 0.01% of the portfolio and ranks #1682 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in NERV as recently as Q1 2015.

Virtu KCG Holdings first reported a position in NERV in Q1 2015 and has held it in 2 quarters since. 82 funds tracked by Wall St. Rank hold NERV as of Q2 2017.

  • Virtu KCG Holdings held 4,192 shares of Minerva Neurosciences worth $297K as of Q2 2017.
  • Minerva Neurosciences was a new Virtu KCG Holdings position in Q2 2017.
  • Minerva Neurosciences made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1682 holding.
  • Virtu KCG Holdings first reported a position in Minerva Neurosciences in Q1 2015 and has held it in 2 quarters since.
  • 82 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.